 2. Treatment with any of the following medications during screening or their expected use during the study: recent systemic glucocorticoids for more than 2 weeks, any anti-hyperglycemic agents, antineoplastic agents, transplant medications, drugs for weight loss, niacin, fibrates, or anti-retroviral medications 